CAPMATINIB for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 838 adverse event reports in the FDA FAERS database where CAPMATINIB was used for Product used for unknown indication.
Most Reported Side Effects for CAPMATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 411 | 17.9% | 410 | 23 |
| Peripheral swelling | 283 | 12.3% | 10 | 34 |
| Fatigue | 257 | 11.2% | 16 | 40 |
| Oedema peripheral | 247 | 10.7% | 25 | 43 |
| Nausea | 240 | 10.4% | 28 | 56 |
| Malignant neoplasm progression | 178 | 7.7% | 79 | 42 |
| Dyspnoea | 141 | 6.1% | 24 | 51 |
| Oedema | 130 | 5.7% | 12 | 17 |
| Asthenia | 113 | 4.9% | 15 | 30 |
| Non-small cell lung cancer | 96 | 4.2% | 37 | 21 |
| Decreased appetite | 95 | 4.1% | 16 | 30 |
| Joint swelling | 92 | 4.0% | 1 | 8 |
| Vomiting | 83 | 3.6% | 11 | 22 |
| Dysphagia | 80 | 3.5% | 11 | 5 |
| Product dose omission issue | 76 | 3.3% | 5 | 15 |
Other Indications for CAPMATINIB
Non-small cell lung cancer (543)
Lung neoplasm malignant (420)
Non-small cell lung cancer metastatic (104)
Lung carcinoma cell type unspecified stage 0 (58)
Lung adenocarcinoma (39)
Non-small cell lung cancer stage iv (31)
Neoplasm malignant (22)
Lung cancer metastatic (20)
Non-small cell lung cancer recurrent (12)
Lung adenocarcinoma stage iv (11)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)